|
|
Matritech is a leading developer of proteomics-based diagnostic products for the early detection of cancer. Using its patented proteomics technology, Matritech has identified proteins correlated with bladder, cervical, breast, prostate and colon cancers. Matritech is one of the first companies to successfully employ proteomics to create diagnostic products.
|
New Bladder Cancer Diagnosis and Monitoring Center Provided by UroToday.com
Supported by an educational grant from Matritech, UroToday.com launched the Bladder Cancer Diagnosis and Monitoring Center. The Center covers clinically relevant publications, current clinical trials, media resources as well as an Ask the Expert area where readers have an opportunity to pose their questions on detection and screening to the center’s highlighted expert.
UroToday's Chief Medical Editor, Alan Wein, MD commented, “UroToday’s addition of a Diagnosis and Monitoring Center for Bladder Cancer directly supports the needs of Urology practices and the needs of healthcare professionals seeking information on early diagnosis and management of bladder cancer.”
Visit the Bladder Cancer Diagnosis and Monitoring Center at UroToday.com
|
|
|
 |
|
